International Journal of Arrhythmia

  • 제19권3호
  • /
  • Pages.186-234
  • /
  • 2018
  • /
  • 2466-0981(pISSN)
  • /
  • 2466-1171(eISSN)
대한부정맥학회 (Korean Heart Rhythm Society)
권호 표지
DOI QR코드

DOI QR Code

2018 심방세동 카테터 절제술 대한민국 진료지침: PART I

  • 투고 : 2018.12.05
  • 심사 : 2018.12.19
  • 발행 : 2018.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Catheter and surgical ablation of atrial fibrillation (AF) have evolved from investigational procedures to their current role as effective treatment options for patients with AF. Surgical ablation of AF is available in most major hospitals throughout the world. Catheter ablation of AF is even more widely available, and is now the most commonly performed catheter ablation procedure. Management of patients with AF has traditionally consisted of three main components: (1) anticoagulation for stroke prevention; (2) rate control; and (3) rhythm control. With the emergence of large amounts of data, which have both defined and called attention to the interaction between modifiable risk factors and the development of AF and outcomes of AF management, we believe it is time to include risk factor modification as the fourth pillar of AF management. Catheter and surgical ablation of AF are highly complex procedures, therefore a decision to perform catheter or surgical AF ablation should only be made after a patient carefully considers the risks, benefits, and alternatives to the procedure.

키워드

참고문헌

  1. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V. A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation. J Am Coll Cardiol. 2006;48:2340-2347. https://doi.org/10.1016/j.jacc.2006.08.037
  2. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216-221. https://doi.org/10.1093/eurheartj/ehi583
  3. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clementy J, Haissaguerre M. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial FibrillationCLINICAL PERSPECTIVE: The A4 Study. Circulation. 2008;118:2498-2505. https://doi.org/10.1161/CIRCULATIONAHA.108.772582
  4. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency AblationCLINICAL PERSPECTIVE: Two Systematic Literature Reviews and Meta-Analyses. Circ Arrhythm Electrophysiol. 2009;2:349-361. https://doi.org/10.1161/CIRCEP.108.824789
  5. Wilber DJ, Pappone C, Neuzil P, Paola AD, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, Investigators for the TAT. Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial. JAMA. 2010;303:333-340. https://doi.org/10.1001/jama.2009.2029
  6. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationFirst Results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol. 2013;61:1713-1723. https://doi.org/10.1016/j.jacc.2012.11.064
  7. Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE. Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter. J Am Coll Cardiol. 2014;64:647-656. https://doi.org/10.1016/j.jacc.2014.04.072
  8. Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque JP, Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert H, Mansour M. Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study. Circulation. 2015;132:907-915. https://doi.org/10.1161/CIRCULATIONAHA.114.014092
  9. Kuck KH, Brugada J, Furnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation N Engl J Med. 2016;374:2235-2245. https://doi.org/10.1056/NEJMoa1602014
  10. Verma A, Jiang C, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque J-P, Nardi S, Menardi E, Novak P, Sanders P. Approaches to Catheter Ablation for Persistent Atrial Fibrillation. N Engl J Med. 2015;372:1812-1822. https://doi.org/10.1056/NEJMoa1408288
  11. Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, Ramoul K, Komatsu Y, Roten L, Jadidi A, Linton N, Pedersen M, Daly M, O'Neill M, Knecht S, Weerasooriya R, Rostock T, Manninger M, Cochet H, Shah AJ, Yeim S, Denis A, Derval N, Hocini M, Sacher F, Haissaguerre M, Jais P. Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint. Circ Arrhythm Electrophysiol. 2015;8:18-24. https://doi.org/10.1161/CIRCEP.114.001943
  12. Hummel J, Michaud G, Hoyt R, DeLurgio D, Rasekh A, Kusumoto F, Giudici M, Dan D, Tschopp D, Calkins H, Boersma L. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014;11:202-209. https://doi.org/10.1016/j.hrthm.2013.11.009
  13. Bassiouny M, Saliba W, Hussein A, Rickard J, Diab M, Aman W, Dresing T, Thomas Callahan, Bhargava M, Martin DO, Shao M, Baranowski B, Tarakji K, Tchou PJ, Hakim A, Kanj M, Lindsay B, Wazni O. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e003596.
  14. Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation. N Engl J Med. 2006;8.
  15. Mont L, Bisbal F, Hernandez-Madrid A, Perez-Castellano N, Vinolas X, Arenal A, Arribas F, Fernandez-Lozano I, Bodegas A, Cobos A, Matia R, Perez-Villacastin J, Guerra JM, Avila P, Lopez-Gil M, Castro V, Arana JI, Brugada J. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2013;eht457.
  16. Kim J-S, Shin SY, Na JO, Choi CU, Kim SH, Kim JW, Kim EJ, Rha S-W, Park CG, Seo HS, Oh DJ, Hwang C, Lim HE. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation? Int J Cardiol. 2015;181:277-283. https://doi.org/10.1016/j.ijcard.2014.12.035
  17. Yu HT, Shim J, Park J, Kim I-S, Kim T-H, Uhm J-S, Joung B, Lee M-H, Kim Y-H, Pak H-N. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study. Circ Arrhythm Electrophysiol. 2017;10:e004915.
  18. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA. 2005;293:2634-2640. https://doi.org/10.1001/jama.293.21.2634
  19. Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation. N Engl J Med. 2012;367:1587-1595. https://doi.org/10.1056/NEJMoa1113566
  20. Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial. JAMA. 2014;311:692-700. https://doi.org/10.1001/jama.2014.467
  21. Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJP. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. EP Eur. 2015;17:370-378.
  22. Hocini M. Reverse Remodeling of Sinus Node Function After Catheter Ablation of Atrial Fibrillation in Patients With Prolonged Sinus Pauses. Circulation. 2003;108:1172-1175. https://doi.org/10.1161/01.CIR.0000090685.13169.07
  23. Chen YW, Bai R, Lin T, Salim M, Sang CH, Long DY, Yu RH, Tang RB, Guo XY, Yan XL, Nie JG, Du X, Dong JZ, Ma CS. Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation-Related Tachycardia-Bradycardia Syndrome? Pacing Clin Electrophysiol. 2014;37:403-411. https://doi.org/10.1111/pace.12340
  24. Inada K, Yamane T, Tokutake K, Yokoyama K, Mishima T, Hioki M, Narui R, Ito K, Tanigawa S, Yamashita S, Tokuda M, Matsuo S, Shibayama K, Miyanaga S, Date T, Sugimoto K, Yoshimura M. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2014;16:208-213. https://doi.org/10.1093/europace/eut159
  25. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M, Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-Lugones A, Abdul-Karim A, Saliba W, Natale A. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol. 2004;43:1004-1009. https://doi.org/10.1016/j.jacc.2003.09.056
  26. Gentlesk PJ, Sauer WH, Gerstenfeld EP, Lin D, Dixit S, Zado E, Callans D, Marchlinski FE. Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation. J Cardiovasc Electrophysiol. 2006;18:9-14.
  27. Khan MN, Jais P, Cummings J, Di Biase L, Sanders P, Martin DO, Kautzner J, Hao S, Themistoclakis S, Fanelli R, Potenza D, Massaro R, Wazni O, Schweikert R, Saliba W, Wang P, Al-Ahmad A, Beheiry S, Santarelli P, Starling RC, Russo AD, Pelargonio G, Brachmann J, Schibgilla V, Bonso A, Casella M, Raviele A, Haissaguerre M, Natale A. Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure. N Engl J Med. 2008;359:1778-1785. https://doi.org/10.1056/NEJMoa0708234
  28. MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, Denvir M, Bhagra S, Small S, Martin W, McMurray JJV, Petrie MC. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97:740-747. https://doi.org/10.1136/hrt.2010.207340
  29. Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ. A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial). Circ Arrhythm Electrophysiol. 2014;7:31-38. https://doi.org/10.1161/CIRCEP.113.000806
  30. Lutomsky BA, Rostock T, Koops A, Steven D, Mullerleile K, Servatius H, Drewitz I, Ueberschar D, Plagemann T, Ventura R, Meinertz T, Willems S. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. EP Eur. 2008;10:593-599.
  31. Choi AD, Hematpour K, Kukin M, Mittal S, Steinberg JS. Ablation vs Medical Therapy in the Setting of Symptomatic Atrial Fibrillation and Left Ventricular Dysfunction. Congest Heart Fail. 2010;16:10-14. https://doi.org/10.1111/j.1751-7133.2009.00116.x
  32. Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T. A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure. J Am Coll Cardiol. 2013;61:1894-1903. https://doi.org/10.1016/j.jacc.2013.01.069
  33. Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M, Kawamura R, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K. Efficacy, Safety, and Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2013;62:1857-1865. https://doi.org/10.1016/j.jacc.2013.07.020
  34. Halabi SA, Qintar M, Hussein A, Alraies MC, Jones DG, Wong T, MacDonald MR, Petrie MC, Cantillon D, Tarakji KG, Kanj M, Bhargava M, Varma N, Baranowski B, Wilkoff BL, Wazni O, Callahan T, Saliba W, Chung MK. Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. JACC Clin Electrophysiol. 2015;1:200. https://doi.org/10.1016/j.jacep.2015.02.018
  35. Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD. Five-Year Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction. J Cardiovasc Electrophysiol. 2015;26:363-370. https://doi.org/10.1111/jce.12602
  36. Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013;10:1334-1339. https://doi.org/10.1016/j.hrthm.2013.06.019
  37. Li-Fern H, Pierre J, Prashanthan S, Stephane G, Meleze H, Frederic S, Yoshihide T, Martin R, Jean-Luc P, Christophe S, Pierre B, Jacques C, Michel H. Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure. N Engl J Med. 2004;11.
  38. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378:417-427. https://doi.org/10.1056/NEJMoa1707855
  39. Kusumoto F, Prussak K, Wiesinger M, Pullen T, Lynady C. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol. 2009;25:31-35. https://doi.org/10.1007/s10840-008-9346-7
  40. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Day JD. Long-Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians. Pacing Clin Electrophysiol. 2009;33:146-152.
  41. Santangeli P, Di Biase L, Mohanty P, Burkhardt JD, Horton R, Bai R, Mohanty S, Pump A, Gibson D, Couts L, Hongo R, Beheiry S, Natale A. Catheter Ablation of Atrial Fibrillation in Octogenarians: Safety and Outcomes. J Cardiovasc Electrophysiol. 2012;23:687-693. https://doi.org/10.1111/j.1540-8167.2012.02293.x
  42. Nademanee K, Amnueypol M, Lee F, Drew CM, Suwannasri W, Schwab MC, Veerakul G. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12:44-51. https://doi.org/10.1016/j.hrthm.2014.09.049
  43. Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD. The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. J Cardiovasc Electrophysiol. 2016;27:141-146. https://doi.org/10.1111/jce.12849
  44. Metzner I, Wissner E, Tilz RR, Rillig A, Mathew S, Schmidt B, Chun J, Wohlmuth P, Deiss S, Lemes C, Maurer T, Fink T, Heeger C, Ouyang F, Kuck K-H, Metzner A. Ablation of atrial fibrillation in patients ${\geq}75$ years: long-term clinical outcome and safety. EP Eur. 2016;18:543-549.
  45. Bunch TJ, Munger TM, Friedman PA, Asirvatham SJ, Brady PA, Cha YM, Rea RF, Shen WK, Powell BD, Ommen SR, Monahan KH, Haroldson JM, Packer DL. Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19:1009-1014. https://doi.org/10.1111/j.1540-8167.2008.01192.x
  46. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy. Circulation. 2001;104:2517-2524. https://doi.org/10.1161/hc4601.097997
  47. Providencia R, Elliott P, Patel K, McCready J, Babu G, Srinivasan N, Bronis K, Papageorgiou N, Chow A, Rowland E, Lowe M, Segal OR, Lambiase PD. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and metaanalysis. Heart. 2016;102:1533-1543. https://doi.org/10.1136/heartjnl-2016-309406
  48. Roh S-Y, Kim D-H, Ahn J, Lee KN, Lee DI, Shim J, Choi J-I, Park S-W, Kim Y-H. Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:788-795. https://doi.org/10.1111/jce.12985
  49. Leong-Sit P, Zado E, Callans DJ, Garcia F, Lin D, Dixit S, Bala R, Riley MP, Hutchinson MD, Cooper J, Gerstenfeld EP, Marchlinski FE. Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of AgeClinical Perspective. Circ Arrhythm Electrophysiol. 2010;3:452-457. https://doi.org/10.1161/CIRCEP.110.938860
  50. Chun KRJ, Schmidt B, Kuck K-H, Andresen D, Willems S, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Seidl K, Junger C, Horack M, Brachmann J, Senges J. Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry. Clin Res Cardiol. 2013;102:459-468. https://doi.org/10.1007/s00392-013-0553-6
  51. Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, Nadal M, Andreu D, Vidal B, Sitges M, Brugada J. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. EP Eur. 2010;12:30-36.
  52. Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, Alzand B, Willems R, Heidbuchel H. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. EP Eur. 2011;13:1386-1393.
  53. Forleo GB, De Martino G, Mantica M, Carreras G, Parisi Q, Zingarini G, Panigada S, Romano E, Dello Russo A, Di Biase L, Natale A, Tondo C. Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation: The IRON-AF (Italian Registry on NavX Atrial Fibrillation Ablation Procedures) study. Int J Cardiol. 2013;168:3968-3970. https://doi.org/10.1016/j.ijcard.2013.06.132
  54. Wu L, Lu Y, Zheng L, Qiao YU, Chen G, Ding L, Hou B, Sun W, Liew R, Zhang S, Yao Y. Comparison of Radiofrequency Catheter Ablation Between Asymptomatic and Symptomatic Persistent Atrial Fibrillation: A Propensity Score Matched Analysis. J Cardiovasc Electrophysiol. 2016;27:531-535. https://doi.org/10.1111/jce.12930
  55. Mohanty S, Santangeli P, Mohanty P, Di Biase L, Holcomb S, Trivedi C, Bai R, Burkhardt D, Hongo R, Hao S, Beheiry S, Santoro F, Forleo G, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Natale A. Catheter Ablation of Asymptomatic Longstanding Persistent Atrial Fibrillation: Impact on Quality of Life, Exercise Performance, Arrhythmia Perception, and Arrhythmia-Free Survival. J Cardiovasc Electrophysiol. 2014;25:1057-1064. https://doi.org/10.1111/jce.12467
  56. Badhwar V, Rankin JS, He X, Jacobs JP, Gammie JS, Furnary AP, Fazzalari FL, Han J, O'Brien SM, Shahian DM. The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg. 2016;101:2265-2271. https://doi.org/10.1016/j.athoracsur.2015.11.049
  57. Filho CACA, Lisboa LAF, Dallan LAO, Spina GS, Grinberg M, Scanavacca M, Sosa EA, Ramires JAF, Oliveira SA. Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease. Circulation. 2005;112:I-20-I-25.
  58. Doukas G, Samani NJ, Alexiou C, Oc M, Chin DT, Stafford PG, Ng LL, Spyt TJ. Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Randomized Controlled Trial. JAMA. 2005;294:2323-2329. https://doi.org/10.1001/jama.294.18.2323
  59. Blomstrom-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensen SM, Thelin S, Holmgren A, Edvardsson N, Kallner G, Blomstrom P. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J. 2007;28:2902-2908. https://doi.org/10.1093/eurheartj/ehm378
  60. Chevalier P, Leizorovicz A, Maureira P, Carteaux J-P, Corbineau H, Caus T, DeBreyne B, Mabot P, Dechillou C, Deharo J-C, Barry S, Touboul P, Villemot J-P, Obadia J-F. Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR). Arch Cardiovasc Dis. 2009;102:769-775. https://doi.org/10.1016/j.acvd.2009.08.010
  61. Budera P, Straka Z, Osmancik P, Vanek T, Jelinek S, Hlavicka J, Fojt R, Cervinka P, Hulman M, Smid M, Maly M, Widimsky P. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644-2652. https://doi.org/10.1093/eurheartj/ehs290
  62. Phan K, Xie A, Meir ML, Black D, Yan TD. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart. 2014;100:722-730. https://doi.org/10.1136/heartjnl-2013-305351
  63. Gillinov AM, Gelijns AC, Parides MK, DeRose JJ, Moskowitz AJ, Voisine P, Ailawadi G, Bouchard D, Smith PK, Mack MJ, Acker MA, Mullen JC, Rose EA, Chang HL, Puskas JD, Couderc J-P, Gardner TJ, Varghese R, Horvath KA, Bolling SF, Michler RE, Geller NL, Ascheim DD, Miller MA, Bagiella E, Moquete EG, Williams P, Taddei-Peters WC, O'Gara PT, Blackstone EH, Argenziano M. Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery. N Engl J Med. 2015;372:1399-1409. https://doi.org/10.1056/NEJMoa1500528
  64. Rankin JS, He X, O'Brien SM, Jacobs JP, Welke KF, Filardo G, Shahian DM. The Society of Thoracic Surgeons Risk Model for Operative Mortality After Multiple Valve Surgery. Ann Thorac Surg. 2013;95:1484-1490. https://doi.org/10.1016/j.athoracsur.2012.11.077
  65. Louagie Y, Buche M, Eucher P, Schoevaerdts J-C, Gerard M, Jamart J, Blommaert D. Improved Patient Survival With Concomitant Cox Maze III Procedure Compared With Heart Surgery Alone. Ann Thorac Surg. 2009;87:440-446. https://doi.org/10.1016/j.athoracsur.2008.10.001
  66. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis. J Thorac Cardiovasc Surg. 2006;131:1029-1035. https://doi.org/10.1016/j.jtcvs.2005.10.020
  67. Kim HJ, Kim JB, Jung S-H, Choo SJ, Chung CH, Lee JW. Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery. Heart. 2016;102:1206-1214. https://doi.org/10.1136/heartjnl-2015-308482
  68. Edgerton JR, Jackman WM, Mack MJ. A New Epicardial Lesion Set for Minimal Access Left Atrial Maze: The Dallas Lesion Set. Ann Thorac Surg. 2009;88:1655-1657. https://doi.org/10.1016/j.athoracsur.2009.05.046
  69. Edgerton JR, Jackman WM, Mahoney C, Mack MJ. Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the "Dallas" lesion set. Heart Rhythm. 2009;6:S64-S70. https://doi.org/10.1016/j.hrthm.2009.09.011
  70. Lockwood D, Nakagawa H, Peyton MD, Edgerton JR, Scherlag BJ, Sivaram CA, Po SS, Beckman KJ, Abedin M, Jackman WM. Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: Techniques for assessing conduction block across surgical lesions. Heart Rhythm. 2009;6:S50-S63. https://doi.org/10.1016/j.hrthm.2009.09.010
  71. Cherniavsky A, Kareva Y, Pak I, Rakhmonov S, Pokushalov E, Romanov A, Karaskov A. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders. Interact Cardiovasc Thorac Surg. 2014;18:727-731. https://doi.org/10.1093/icvts/ivu016
  72. Yoo JS, Kim JB, Ro SK, Jung Y, Jung S-H, Choo SJ, Lee JW, Chung CH. Impact of Concomitant Surgical Atrial Fibrillation Ablation in Patients Undergoing Aortic Valve Replacement. Circ J. 2014;78:1364-1371. https://doi.org/10.1253/circj.CJ-13-1533
  73. Driessen AHG, Berger WR, Krul SPJ, van den Berg NWE, Neefs J, Piersma FR, Chan Pin Yin DRPP, de Jong JSSG, van Boven WP, de Groot JR. Ganglion Plexus Ablation in Advanced Atrial Fibrillation. J Am Coll Cardiol. 2016;68:1155-1165. https://doi.org/10.1016/j.jacc.2016.06.036
  74. Boersma LVA, Castella M, Boven W van, Berruezo A, Yilmaz A, Nadal M, Sandoval E, Calvo N, Brugada J, Kelder J, Wijffels M, Mont L. Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST)Clinical Perspective: A 2-Center Randomized Clinical Trial. Circulation. 2012;125:23-30. https://doi.org/10.1161/CIRCULATIONAHA.111.074047
  75. Henn MC, Lancaster TS, Miller JR, Sinn LA, Schuessler RB, Moon MR, Melby SJ, Maniar HS, Damiano RJ. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2015;150:1168-1178.e2. https://doi.org/10.1016/j.jtcvs.2015.07.102
  76. Krul SPJ, Driessen AHG, Zwinderman AH, van Boven WJ, Wilde AAM, de Bakker JMT, de Groot JR. Navigating the minimaze: Systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol. 2013;166:132-140. https://doi.org/10.1016/j.ijcard.2011.10.011
  77. Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB, Gillinov AM. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:797-802. https://doi.org/10.1016/j.jtcvs.2005.03.041
  78. Edgerton JR, Edgerton ZJ, Weaver T, Reed K, Prince S, Herbert MA, Mack MJ. Minimally Invasive Pulmonary Vein Isolation and Partial Autonomic Denervation for Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg. 2008;86:35-39. https://doi.org/10.1016/j.athoracsur.2008.03.071
  79. Edgerton JR, McClelland JH, Duke D, Gerdisch MW, Steinberg BM, Bronleewe SH, Prince SL, Herbert MA, Hoffman S, Mack MJ. Minimally invasive surgical ablation of atrial fibrillation: Sixmonth results. J Thorac Cardiovasc Surg. 2009;138:109-114. https://doi.org/10.1016/j.jtcvs.2008.09.080
  80. Beyer E, Lee R, Lam B-K. Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: Early multicenter results. J Thorac Cardiovasc Surg. 2009;137:521-526. https://doi.org/10.1016/j.jtcvs.2008.11.031
  81. Kearney K, Stephenson R, Phan K, Chan WY, Huang MY, Yan TD. A systematic review of surgical ablation versus catheter ablation for atrial fibrillation. Ann Cardiothorac Surg. 2014;3:15-29.
  82. Ad N, Suri RM, Gammie JS, Sheng S, O'Brien SM, Henry L. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg. 2012;144:1051-1060. https://doi.org/10.1016/j.jtcvs.2012.07.065
  83. Driessen AHG, Berger WR, Chan Pin Yin DRPP, Piersma FR, Neefs J, van den Berg NWE, Krul SPJ, van Boven WP, de Groot JR. Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation. J Am Coll Cardiol. 2017;69:1753-1754.
  84. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005;27:258-265. https://doi.org/10.1016/j.ejcts.2004.11.003
  85. Wazni OM, Saliba W, Fahmy T, Lakkireddy D, Thal S, Kanj M, Martin DO, Burkhardt JD, Schweikert R, Natale A. Atrial Arrhythmias After Surgical Maze. J Am Coll Cardiol. 2006;48:1405-1409. https://doi.org/10.1016/j.jacc.2006.05.061
  86. Magnano AR, Argenziano M, Dizon JM, Vigilance D, Williams M, Yegen H, Rueter K, Oz M, Garan H. Mechanisms of Atrial Tachyarrhythmias Following Surgical Atrial Fibrillation Ablation. J Cardiovasc Electrophysiol. 2006;17:366-373. https://doi.org/10.1111/j.1540-8167.2006.00419.x
  87. McElderry HT, McGiffin DC, Plumb VJ, Nanthakumar K, Epstein AE, Yamada T, Kay GN. Proarrhythmic Aspects of Atrial Fibrillation Surgery: Mechanisms of Postoperative Macroreentrant Tachycardias. Circulation. 2008;117:155-162. https://doi.org/10.1161/CIRCULATIONAHA.107.688358
  88. McCarthy PM, Kruse J, Shalli S, Ilkhanoff L, Goldberger JJ, Kadish AH, Arora R, Lee R. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovasc Surg. 2010;139:860-867. https://doi.org/10.1016/j.jtcvs.2009.12.038
  89. Zeng Y, Cui Y, Li Y, Liu X, Xu C, Han J, Meng X. Recurrent Atrial Arrhythmia After Minimally Invasive Pulmonary Vein Isolation for Atrial Fibrillation. Ann Thorac Surg. 2010;90:510-515. https://doi.org/10.1016/j.athoracsur.2010.04.063

피인용 문헌

  1. Association of pericardial effusion after pulmonary vein isolation and outcomes in patients with paroxysmal atrial fibrillation vol.43, pp.10, 2018, https://doi.org/10.1111/pace.14045
  2. Clinical outcomes after pulmonary vein isolation using an automated tagging module in patients with paroxysmal atrial fibrillation vol.21, pp.1, 2018, https://doi.org/10.1186/s42444-020-00021-9